Form 4 for ELDN Eledon Pharmaceuticals, Inc.
Accepted 2021-12-21 00:00:00 ET · period of report 2021-12-20 · accession 0000899243-21-049171 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-12-21 | 2021-12-20 | ELDN | Gros David-Alexandre C | CEO, Dir | P - Purchase | $4.48 | +2,000 | 9,000 | +29% | +$8,960 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-20 | P | A | 2,000 | $4.48 | 9,000 | D | — | — |